The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia
Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
Randomized, open-label, multicentre study to compare the efficacy and safety of ATRA plus
danazol with danazol monotherapy in patients with corticosteroid-resistant/relapsed ITP.
Phase:
Phase 2
Details
Lead Sponsor:
Peking University People's Hospital
Collaborators:
Beijing Hospital Beijing Municipal Science & Technology Commission Beijing Tongren Hospital Navy General Hospital, Beijing Qilu Hospital of Shandong University